Hyperthyroidism is a syndrome caused by excess circulating thyroid hormones (T3 and/or T4) leading to a hypermetabolic state. The most common cause is Graves' disease (60–80% of cases), an autoimmune condition.
Key concept: Thyrotoxicosis = symptoms from excess thyroid hormone (any source). Hyperthyroidism = excess production by the thyroid gland itself.
Lid Lag vs Lid Retraction: Lid lag = upper lid lags behind globe on downward gaze (all causes of thyrotoxicosis — sympathetic stimulation). Lid retraction = upper lid sits abnormally high at rest (specific to Graves' ophthalmopathy — autoimmune).
⚡Amiodarone-Induced Thyrotoxicosis (AIT)
Type 1 AIT: Pre-existing thyroid abnormality + iodine load → excess synthesis. Treat with carbimazole/PTU.
Type 2 AIT: Destructive thyroiditis in a normal gland → hormone release. Treat with corticosteroids.
Amiodarone facts: Contains 37% iodine by weight. Half-life 40–55 days. Can cause hypo OR hyperthyroidism. Does NOT need to be stopped for mild cases.
Baseline; monitor if symptomatic (jaundice, RUQ pain)
TFTs
Monitor treatment response
Repeat 4–6 weeks after dose change; then 3-monthly
ECG
AF is common complication; QTc monitoring
All new diagnoses; rate control with beta-blocker if AF
Bone density (DEXA)
Subclinical/overt hyperthyroidism → osteoporosis
Consider in post-menopausal women, prolonged disease
Thyroid USS
Nodule characterisation, goitre volume
If palpable nodule, asymmetric goitre, planned RAI
Pregnancy test
Changes management (PTU vs carbimazole)
All women of childbearing age
AGRANULOCYTOSIS WARNING — Patient Education: All patients starting carbimazole or PTU must be counselled: if they develop sore throat, fever, mouth ulcers, or flu-like illness — STOP the drug IMMEDIATELY and attend for urgent FBC. Do NOT wait for routine appointment. Risk: ~0.3% with carbimazole, ~0.3% with PTU. Onset usually within first 3 months.
ECG & Cardiac Monitoring
🫀Atrial Fibrillation in Hyperthyroidism
AF occurs in 10–15% of hyperthyroid patients; risk increases with age and subclinical disease.
Rate control: beta-blockers (propranolol preferred — also blocks T4→T3)
Higher risk of hepatic necrosis vs carbimazole — monitor LFTs closely
Agranulocytosis risk similar to carbimazole (~0.3%)
Less transplacental transfer than carbimazole
⚖️Titration vs Block-Replace Regimen
Feature
Titration Regime
Block-Replace Regime
Principle
Adjust ATD dose to maintain euthyroidism
High ATD dose + levothyroxine replacement
ATD dose
Lower (reduce as TSH normalises)
Fixed high dose (carbimazole 30–40 mg)
Levothyroxine
Not used
Added when euthyroid (100–150 mcg)
Advantages
Lower side-effect burden
Simpler (once daily), stable TFTs
Disadvantages
Frequent TFT monitoring needed
More side effects from higher ATD dose
Use in pregnancy
Preferred
Avoid (LT4 crosses placenta less)
Symptomatic Relief
❤️Beta-Blockers
Propranolol 40 mg TDS (non-selective) — first-line for symptom control
Reduces HR, palpitations, tremor, anxiety
Blocks T4→T3 peripheral conversion
Does NOT reduce thyroid hormone levels
Continue until euthyroid, then wean
Caution with propranolol: • Asthma/COPD — use cardioselective (atenolol/metoprolol) with care or avoid • Heart block / severe bradycardia • Peripheral vascular disease • Diabetes (masks hypoglycaemia)
Definitive Treatment Options
☢️Radioiodine (RAI) I-131
Absorbed by thyroid → beta radiation → ablation
Definitive treatment — most patients eventually hypothyroid
Post-RAI hypothyroidism expected and acceptable — start levothyroxine
Results in 6–24 weeks
Contraindications: Pregnancy, breastfeeding, age <5 years
Caution: Active/moderate-severe Graves' ophthalmopathy (may worsen — use prophylactic steroids)
Stop carbimazole 3–5 days before RAI (reduces effectiveness)
STOP CARBIMAZOLE / PTU IMMEDIATELY if patient develops sore throat, fever ≥38°C, mouth ulcers, or malaise. This is a medical emergency.
1
Patient education at initiation: Verbal AND written instructions. "If you develop sore throat or fever — stop the tablet, call us immediately, go to A&E."
2
Urgent FBC with differential: Neutrophil count <0.5 × 10⁹/L = agranulocytosis. Risk peak: first 3 months of therapy.
3
Discontinue ATD permanently: Do NOT rechallenge with the same drug. Cross-reactivity between carbimazole and PTU — use different drug class only if essential.
4
Neutropenic sepsis protocol: IV antibiotics, reverse isolation, haematology review, consider G-CSF if severe.
5
Alternative thyroid control: Consider lithium (short-term) to maintain euthyroidism while planning definitive treatment (RAI or surgery).
Note: Routine monitoring FBC is NOT recommended by most guidelines (does not predict agranulocytosis — onset sudden). Education is the key intervention.
THYROID STORM — MORTALITY 10–20% EVEN WITH TREATMENT. ICU-level care required. Act fast. Use the Burch-Wartofsky Point Scale below to confirm diagnosis.
Burch-Wartofsky Point Scale (BWPS) Calculator
Precipitating Factors
⚡Common Precipitants (Remember: "IT SCRIP")
Infection (most common)Trauma / SurgeryContrast media / Iodine loadRadioiodine (RAI)Parturition / LabourNon-compliance with ATDsDKA / Metabolic stressPulmonary embolism
GCC-specific precipitant: Extreme heat exposure (outdoor workers, Hajj/Umrah pilgrims) — heat stress can precipitate thyroid storm in undiagnosed or undertreated hyperthyroid patients.
Thyroid Storm Management Bundle
CRITICAL: PTU MUST be given BEFORE Lugol's iodine. If iodine is given first, it provides substrate for hormone synthesis. PTU blocks synthesis first, then iodine blocks release.
Step 1 — Block Synthesis
PTU (Propylthiouracil)
Loading dose: 500–1000 mg orally/via NGT, then 250 mg every 4 hours
Blocks new hormone synthesis + inhibits T4→T3 peripheral conversion. Give FIRST.
▼ Wait 1 hour ▼
Step 2 — Block Release (1 hour after PTU)
Lugol's Iodine (Saturated Solution of Potassium Iodide — SSKI)
Lugol's iodine 5–10 drops orally every 6–8 hours, OR potassium iodide 250 mg TDS
Cooling measures (tepid sponging, fan — NOT aspirin which displaces T4 from binding proteins) | IV fluids | Glucose monitoring | Anticoagulation if AF | Broad-spectrum antibiotics if infection suspected | Cholestyramine (binds T4 in gut — adjunct)
Address underlying precipitant — this is essential for resolution.
🌡️Nursing Priorities in Thyroid Storm
Continuous cardiac monitoring (telemetry)
Core temperature monitoring — active cooling
Hourly urine output — fluid balance chart
Neuro-obs every 1–2 hours (GCS)
Blood glucose monitoring 1–2 hourly
Ensure medication timing sequence is correct
Patient/family communication & anxiety management
Aspiration precautions (nausea/vomiting)
DVT prophylaxis (high-risk state)
Calorie-dense nutrition support
Do NOT use aspirin/salicylates for fever — displaces T4/T3 from thyroid-binding globulin, worsening thyrotoxicosis. Use paracetamol (acetaminophen) + tepid sponging + cooling blanket.
Graves' Ophthalmopathy (GO) / Thyroid Eye Disease (TED) is an autoimmune orbital inflammation affecting ~25–50% of Graves' patients. It can occur with hypo-, eu- or hyperthyroidism. Smoking is the single most important modifiable risk factor.
Clinical Activity Score (CAS)
👁️CAS Assessment (0–7 points)
#
Feature
Points
1
Spontaneous retrobulbar pain
1
2
Pain on eye movement
1
3
Eyelid redness (erythema)
1
4
Conjunctival redness (injection)
1
5
Lid swelling (oedema)
1
6
Conjunctival swelling (chemosis)
1
7
Swelling of the caruncle
1
CAS ≥3/7 = Active disease → consider IV methylprednisolone
CAS <3/7 = Inactive disease → supportive nursing care, selenium if mild
EUGOGO Classification
📊European Group on Graves' Orbitopathy Severity
Severity
Features
Management
Mild
Minor lid retraction <2mm, mild soft tissue, exophthalmos <3mm above normal, transient/no diplopia, exposure keratopathy responsive to drops
DiplopiaFibrosis of extraocular muscles (inferior rectus most common → vertical diplopia)
Exposure KeratopathyCorneal exposure → ulceration from incomplete lid closure (lagophthalmos)
Optic Nerve CompressionMost serious — orbital congestion compresses optic nerve → visual loss (colour first)
Lid RetractionUpper lid sits above superior limbus at rest — "thyroid stare"
ChemosisConjunctival oedema — visible clear swelling around iris
Nursing Eye Care Protocol
1
Lubricating eye drops (artificial tears): Preservative-free drops every 2–4 hours during waking hours. Hypromellose 0.3% or carbomer gel. More viscous preparations for severe exposure.
2
Lubricating eye ointment at night: Lacri-Lube or equivalent thick ointment at bedtime — blurs vision so only use at night.
3
Lid taping at night (lagophthalmos): If eyes do not fully close during sleep — gently tape upper lid to lower lid with hypoallergenic tape. Prevents corneal exposure injury.
4
Moisture chamber spectacles: Wrap-around glasses with moisture-retaining side shields — reduces evaporation, protects from wind/dust. Particularly important in GCC climate.
5
Sunglasses/tinted lenses: Photophobia is common. UV protection important outdoors.
6
Head elevation at night: Elevate head of bed 30–45° — reduces periorbital oedema by gravity-dependent drainage. Use extra pillows.
7
Smoking cessation: Strongest modifiable risk factor. Doubles risk of GO. Impairs response to treatment. Refer to cessation service.
8
Vision monitoring — RED FLAGS: Any sudden change in colour vision, blurred vision despite drops, or severe pain → urgent ophthalmology review (possible optic nerve compression).
9
Selenium 200 mcg/day × 6 months: Evidence-based for mild active GO (EUGOGO recommendation). Reduces selenium deficiency-related oxidative stress in orbital tissues.
Euthyroid state maintenance: Achieving and maintaining euthyroidism is critical — hyperthyroidism AND hypothyroidism can worsen GO. Avoid post-RAI hypothyroidism; cover RAI with oral steroids if active GO present.
💉Medical Treatment — IV Methylprednisolone
Standard regimen: 500 mg IV weekly × 6 weeks, then 250 mg IV weekly × 6 weeks (cumulative max ~8g)
Administer in specialist centre — monitor BP, glucose, electrolytes
Check hepatic function before starting (risk of acute liver injury — avoid if hepatitis)
PPI gastroprotection + monitor blood sugar (steroid-induced hyperglycaemia)
Orbital radiotherapy: adjunct to IV steroids for moderate-severe disease
GCC-Specific Clinical Considerations
🌍Iodine Status in GCC
Historically varied — some areas deficient, others sufficient
Post-fortification (iodised salt) most GCC countries now iodine-sufficient
Iodine sufficiency → relative ↑ in Graves' disease prevalence
Iodine excess (supplements, contrast, amiodarone) → risk of iodine-induced hyperthyroidism in nodular goitres
Iodine intake screening relevant in thyroid patient education
🌡️Extreme Heat — Thyroid Storm Risk
GCC summer temperatures can exceed 50°C
Heat stress → increased metabolic demand → can precipitate thyroid storm in untreated/undertreated hyperthyroidism
Outdoor workers (construction, agriculture) at highest risk
TRAb monitoring — high levels at 30–36 weeks → neonatal Graves' risk
Neonatal monitoring: TFTs at birth and 3–5 days (if maternal TRAb elevated)
RAI contraindicated throughout pregnancy and breastfeeding
Regulatory & Competency Framework
📋GCC Nursing Regulatory Bodies
Body
Country
Relevance to Thyroid Nursing
DHA — Dubai Health Authority
UAE (Dubai)
DHA exam includes endocrine nursing; OMSB aligned competencies
DOH — Department of Health
UAE (Abu Dhabi)
HAAD-based competency framework; thyroid monitoring in NCD care
SCFHS — Saudi Commission for Health Specialties
Saudi Arabia
Thyroid storm and endocrine emergencies in nurse licensing exam content
QCHP — Qatar Council for Healthcare Practitioners
Qatar
Endocrine pharmacology including carbimazole safety featured in exam
MOH
Oman, Bahrain, Kuwait
Aligned with GCC mutual recognition framework
GCC Exam Prep — MCQs
DHA / MOH / SCFHS / QCHP Style Questions — Review all options before checking the answer below each question.
Q1. A 28-year-old female presents with weight loss, palpitations, and exophthalmos. TSH is 0.02 mIU/L, FT4 is elevated. Which antibody MOST specifically confirms the aetiology?
A. Anti-TPO antibodies
B. Anti-thyroglobulin antibodies
C. TSH receptor antibodies (TRAb)
D. Anti-nuclear antibodies (ANA)
Answer: C — TRAb TRAb (TSH receptor-stimulating antibodies) are the pathognomonic antibody in Graves' disease. They stimulate the TSH receptor, causing continuous thyroid hormone production. Exophthalmos in this scenario confirms Graves' ophthalmopathy. Anti-TPO is present in many autoimmune thyroid conditions and is not specific.
Q2. A patient on carbimazole for 6 weeks develops a sore throat and fever of 38.5°C. What is the PRIORITY nursing action?
A. Advise the patient to take paracetamol and monitor at home
B. Schedule a routine outpatient appointment for next week
C. Instruct the patient to stop carbimazole immediately and arrange urgent FBC
D. Reduce the carbimazole dose by half and recheck TFTs in 4 weeks
Answer: C — Stop carbimazole, urgent FBC Sore throat and fever in a patient on carbimazole must be treated as agranulocytosis until proven otherwise. The drug must be stopped immediately and an urgent full blood count obtained. Neutrophil count <0.5 × 10⁹/L confirms agranulocytosis — a potentially fatal complication. Delay is dangerous.
Q3. A patient in suspected thyroid storm is about to receive Lugol's iodine and PTU. In which ORDER should these medications be given?
A. Lugol's iodine first, then PTU 30 minutes later
B. Both can be given simultaneously — order does not matter
C. PTU first, then Lugol's iodine at least 1 hour later
D. Lugol's iodine only — PTU is contraindicated in thyroid storm
Answer: C — PTU first, then Lugol's iodine (1 hour later) PTU must be given first to block thyroid peroxidase and halt new hormone synthesis. If iodine is given first, it provides substrate for a "thyroid burst" — accelerating hormone synthesis before synthesis is blocked. PTU is actually PREFERRED in thyroid storm over carbimazole due to its additional ability to block peripheral T4→T3 conversion.
Q4. A nurse is counselling a patient with Graves' ophthalmopathy about self-care. Which advice is MOST important?
A. Avoid all eye drops as they may worsen inflammation
B. Stop smoking — it significantly worsens thyroid eye disease and reduces treatment response
C. Wear contact lenses to protect the cornea during the day
D. Apply warm compresses twice daily to reduce proptosis
Answer: B — Smoking cessation Smoking is the single most important modifiable risk factor for Graves' ophthalmopathy. It approximately doubles the risk of developing GO, increases its severity, and significantly reduces the response to immunosuppressive treatment including IV methylprednisolone. Contact lenses are contraindicated in GO due to exposure keratopathy risk.
Q5. A pregnant woman at 8 weeks gestation is diagnosed with Graves' hyperthyroidism requiring antithyroid drug therapy. Which drug is PREFERRED at this gestational age?
A. Carbimazole 20 mg daily — safest in all trimesters
B. Radioiodine I-131 — provides definitive control during pregnancy
C. Propylthiouracil (PTU) — preferred in the 1st trimester
D. Lithium — safe thyroid suppressor in pregnancy
Answer: C — PTU in 1st trimester PTU is preferred in the first trimester because carbimazole is associated with a specific embryopathy (aplasia cutis, choanal atresia, oesophageal/choanal atresia — "MMI/carbimazole embryopathy") during organogenesis (weeks 6–10). Radioiodine is absolutely contraindicated in pregnancy (destroys fetal thyroid). After the first trimester, many guidelines recommend switching to carbimazole due to PTU's risk of hepatic necrosis in the mother.
📖Key Exam Mnemonics & Fast Facts
Graves' Triad
Diffuse goitre + Exophthalmos + Pretibial myxoedema (not all present simultaneously — only ~10% have all three)